Latest filing published 09 Nov 2016 for Abeona Therapeutics INC., €314k.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +267.9%Entry US$16,800.00 · Close at T+365 US$61,800.00
- +3.7%Entry US$40,500.00 · Close at T+365 US$42,000.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Mark J. Ahn: trading record in brief
Mark J. Ahn discloses dealings in 3 companies, chiefly SELLAS Life Sciences Group, Inc., Hana Biosciences Inc and Abeona Therapeutics Inc. Between 7 February 2006 and 8 November 2016, the trades on record add up to 29 filings.
Both buying and selling appear: 6 purchases worth €240k, against 1 sale worth €2.8M. Sales outweigh purchases by €2.6M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 6 share grants and 9 option exercises.
Half of the purchases are above €24k and half below.
The latest filing, published on 9 November 2016, reports an option exercise of €314k in Abeona Therapeutics Inc. The last insider purchase was made public on 3 August 2015, 4,116 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mark J. Ahn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 150,000 shares@ US$2.31100.0% of flowCommon stockSEC:0000318306-16-000048:0
- 18,182 shares@ US$5.50Common stockSEC:0000318306-15-000039:0Canonical exit: 29 Oct 2015 (T+90)
- 300,000 shares0Common stockSEC:0000318306-15-000034:0
- 300,000 shares@ US$7.34Common stockSEC:0000318306-15-000024:0
- 25,000 shares@ US$4.00Common StockSEC:0000318306-15-000002:0Canonical exit: 26 Apr 2015 (T+90)
- 50,000 shares@ US$2.31Common StockSEC:0001250853-14-000035:0
- 100,000 shares@ US$1.38Common StockSEC:0001250853-14-000035:1
- 324,890 shares@ US$1.38Common StockSEC:0001250853-14-000035:2
- 200,000 shares@ US$0.72Common StockSEC:0001250853-14-000035:3
- 121,875 shares@ US$1.71Common StockSEC:0001250853-14-000035:4
- 796,765 shares@ US$4.83Common StockSEC:0001250853-14-000035:5
- 7,862 shares@ US$1.35Common Stock, par value $0.0001SEC:0001554742-13-000003:0
- 7,668 shares@ US$1.30Common Stock, par value $0.0001SEC:0001250853-13-000028:0
- 31,289 shares@ US$0.3995Common Stock, par value $0.0001SEC:0001533613-12-000001:0
- 31,289 shares@ US$0.40Common Stock, par value $.0001SEC:0001422882-12-000001:0
- 10,000 shares@ US$0.659Common Stock, par value $.0001SEC:0001422882-11-000011:0Canonical exit: 6 Mar 2012 (T+90)
- 10,000 shares@ US$0.95Common Stock, par value $.0001SEC:0001209191-11-023604:0Canonical exit: 19 Jul 2011 (T+90)
- 85,000 sharesCommon StockSEC:0001179110-06-014878:0
- 325,000 sharesCommon StockSEC:0001179110-06-014878:1
- 74,887 sharesCommon StockSEC:0001179110-06-014878:2
- 5,500 shares@ US$9.07Common StockSEC:0001179110-06-011286:0Canonical exit: 15 Aug 2006 (T+90)
- 5,000 shares0Common StockSEC:0001179110-06-010506:0
- 164,508 shares@ US$0.167Common StockSEC:0001179110-06-010506:1
- 5,859 shares@ US$1.57Common StockSEC:0001179110-06-010506:2
- 1,000 shares@ US$10.63Common StockSEC:0001179110-06-007208:0Canonical exit: 22 Jun 2006 (T+90)
25 of 25 declarations
